KRTX
Sector: Manufacturing
Industry: Pharmaceutical Products
(%)
Volume:
52 week range:
-
Market Cap:
12.190B
Company Description:
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia.